Paula Salmikangas | Director for Biopharmaceuticals & ATMPs
N.D.A. Regulatory Advisory Board

Paula Salmikangas, Director for Biopharmaceuticals & ATMPs, N.D.A. Regulatory Advisory Board

Dr Paula Salmikangas, Director for Biopharmaceuticals and ATMPs, NDA Advisory Board, is a clinical biochemist by original training with a PhD in muscle
cell biology. Since 2006, she has been an Adjunct Professor of Biochemistry for the University of Helsinki, Finland. Paula joined NDA in 2017, has served as a member of the EMA
Committee for Advanced Therapies (CAT) from 2009 to 2017 and has been the Chair of the CAT 2014-2017. Her main areas of expertise are biological medicinal products,
especially ATMPs, and chemistry, manufacturing and controls aspects of biopharmaceuticals.


Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 11:40

Plenary Round Table Discussion Session: Process Development & Manufacturing Focus

Table 1. Regulatory and scientific challenges for global development

back to speakers

World Advanced Therapies & Regenerative Medicine Congress


Erica Baeta
+44 (0)207 092 1152


Jessica Robinson
t/ +44 (0)207 092 1150


Issa Mauthoor
+44 (0)207 092 1257